Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ida-Lina Diak"'
Autor:
Ida-Lina Diak, Kimberley Swank, Kate McCartan, Maya Beganovic, James Kidd, Neha Gada, Rachna Kapoor, Lisa Wolf, Laura Kangas, Jo Wyeth, Toni Salvatore, Melina Fanari, Andrew A. LeBoeuf, Poonam Mishra, Michael D. Blum, Gerald Dal Pan
Publikováno v:
Drug Safety. 46:145-155
On 4 February, 2020, the Secretary of the Department of Health and Human Services declared a public health emergency related to coronavirus disease 2019 (COVID-19), and on 27 March, 2020 declared circumstances existed to justify the authorization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35e6235fa9e31ac517c9452e4c2f808
https://doi.org/10.1007/s40264-022-01256-2
https://doi.org/10.1007/s40264-022-01256-2
Publikováno v:
Clin Toxicol (Phila)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c966d0442403b3cde5f7745032ca268
https://doi.org/10.1080/15563650.2022.2153693
https://doi.org/10.1080/15563650.2022.2153693
Publikováno v:
Drugs Ther Perspect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c22b89f0b2656007766687c0a2387002
https://pubmed.ncbi.nlm.nih.gov/33505156
https://pubmed.ncbi.nlm.nih.gov/33505156
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 1:112-116
Purpose: Describe our review of the occurrence of acute generalized exanthematous pustulosis (AGEP) with hydroxyzine, and its active metabolites, cetirizine, and levocetirizine.Methods: The Division of Pharmacovigilance of the Food and Drug Administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a98a9f5538df135565276a2ac0358ba
https://doi.org/10.25251/skin.1.3.1
https://doi.org/10.25251/skin.1.3.1
Publikováno v:
J Pediatr
Objective To identify and characterize cases of chemical leukoderma, an underrecognized adverse event, associated with the methylphenidate transdermal system (MTS) reported to the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991c85dfc73c14bfc7988e1ed4849e27
https://doi.org/10.1016/j.jpeds.2016.09.008
https://doi.org/10.1016/j.jpeds.2016.09.008
Publikováno v:
The Annals of pharmacotherapy. 53(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df6ef6a75a870006e94b385e666fcad
https://pubmed.ncbi.nlm.nih.gov/30957522
https://pubmed.ncbi.nlm.nih.gov/30957522
Publikováno v:
The Annals of pharmacotherapy. 53(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8ef641c39319da28de362c6c0904b5
https://pubmed.ncbi.nlm.nih.gov/30600685
https://pubmed.ncbi.nlm.nih.gov/30600685
Publikováno v:
JACC: Heart Failure. 6:721-722
Dr. Dias and colleagues presented some interesting observations about serotonin norepinephrine reuptake inhibitors (SNRIs) and selective serotonin reuptake inhibitors (SSRIs) based on their retrospective descriptive study of Takotsubo syndrome (TTS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::942704328a4f9ccf653273fec3676822
https://doi.org/10.1016/j.jchf.2018.05.014
https://doi.org/10.1016/j.jchf.2018.05.014
Publikováno v:
JACC: Heart Failure. 6:347-348
We read with great interest the perspectives of Tavazzi et al. [(1)][1] regarding Takotsubo syndrome (TTS), neurogenic stress cardiomyopathy, and the prevailing hypothesis of common catecholamine-mediated pathways. The Division of Pharmacovigilance a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::469836f0cd67f8fc2df3f2f3e5362266
https://doi.org/10.1016/j.jchf.2017.12.011
https://doi.org/10.1016/j.jchf.2017.12.011
Publikováno v:
European Journal of Gastroenterology & Hepatology. 29:1102-1103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b166560f5fcefcc87e0c5ef6cd01078
https://doi.org/10.1097/meg.0000000000000894
https://doi.org/10.1097/meg.0000000000000894